Cargando…
Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
Changing insights regarding radioiodine (I-131) administration in differentiated thyroid carcinoma (DTC) stir up discussions on the utility of pre-ablation diagnostic scintigraphy (DxWBS). Our retrospective study qualitatively and semi-quantitatively assessed posttherapy I-131 whole-body scintigraph...
Autores principales: | de Koster, Elizabeth J., Sulaiman, Taban, Hamming, Jaap F., Schepers, Abbey, Snel, Marieke, van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, Vriens, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003652/ https://www.ncbi.nlm.nih.gov/pubmed/33808843 http://dx.doi.org/10.3390/diagnostics11030553 |
Ejemplares similares
-
A clinically applicable molecular classification of oncocytic cell thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2023) -
Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
por: Dotinga, Maaike, et al.
Publicado: (2022) -
Editorial on Special Issue “Quantitative PET and SPECT”
por: van Velden, Floris H. P., et al.
Publicado: (2022) -
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022) -
Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2022)